Home
Conditions
Immunotherapy

Clinical trial condition

Immunotherapy

Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.

216 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Immunotherapy trial results

Not Yet Recruiting

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

NCT06567600

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +6 more
Locations: The Third Affiliated Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

NCT06523049

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

NCT06506396

Conditions: Behavior, CAR T-cell Therapy, Hematologic Diseases, +7 more
Locations: AUSL-IRCCS di Reggio Emilia Reggio Emilia, Italy

View Trial Details

Not Yet Recruiting

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

NCT06490198

Conditions: Adenocarcinoma, Carcinoma, Chemotherapy Effect, +5 more
Locations: Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan

Chang-Gung Memorial Hospital, Linkou Branch Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

NCT05435365

Conditions: Cancer, Immunotherapy, Neoplasms
Locations: Not specified

View Trial Details

Not Yet Recruiting

PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma

NCT06125223

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

NCT05479240

Conditions: Immunotherapy
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

NCT04890522

Conditions: Carcinoma, Chemotherapy, Head and Neck Neoplasms, +19 more
Locations: Department of Radiation Oncology, Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC

NCT04895137

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Sun Yatsen University Guangzhou, Guangdong, China

View Trial Details

Completed

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

NCT07040956

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Department of Radiation Oncology Chengdu, Sichuan, China

View Trial Details

Immunotherapy

Immunotherapy trial results

Related conditions